Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
GE HealthCare Secures FDA 510(k) Clearance for Photonova Spectra Photon-Counting CT
GE HealthCare obtained FDA 510(k) clearance for Photonova Spectra, its photon‑counting CT system. The scanner uses Deep Silicon detectors with 8‑bin energy resolution, delivering simultaneous spectral and high‑definition images in a 0.23‑second rotation. NVIDIA GPU‑accelerated reconstruction handles the 50‑fold data increase, enabling real‑time imaging. The clearance follows a $5.1 billion investment, positioning GE as a strong contender in the premium PCCT market.
Digital Health: Gamifying Recovery with MLB The Show 26
MLB The Show 26, Sony’s flagship baseball simulation, is being repurposed as a digital‑health tool to gamify physical and cognitive rehabilitation. By embedding reward systems, progress tracking, and multiplayer interaction, the game transforms repetitive therapy into an engaging experience. Therapists...
Choosing Alert Types For Quiet Rooms Vs High-Traffic Wards
Patient monitoring systems must align alert methods with room dynamics. In quiet patient rooms, discreet solutions such as pressure‑sensitive pads, low‑volume local alarms, pager alerts, and nurse‑call integration minimize disturbance while still notifying staff. High‑traffic wards require louder audible alarms,...
CLL/SLL Treatment Choices Based on Various Factors
A population‑based study of 148 first‑line CLL/SLL patients in Alberta found that time‑limited venetoclax‑obinutuzumab was used in 51% of cases, while continuous BTK inhibitor therapy accounted for 44%. Patients with del(17p) or TP53 mutations chose BTK inhibitors in 84% of...
Guidance Needed for Doctors Treating DOD, VA Patients Exposed to Jet Fuel in Hawaii Water, Report Says
A National Academies report finds no clinical guidance exists for treating long‑term health effects of JP‑5 jet fuel exposure, which contaminated drinking water for roughly 93,000 residents and service members in Hawaii in 2021. The study documents limited, suggestive evidence...
Samsung Medison to Unify Two U.S. Imaging Businesses as Samsung HME America
Samsung Medison announced that its two U.S. imaging units, Neurologica and Boston Imaging, will merge under the new corporate identity Samsung HME America. The consolidation brings together ultrasound, digital radiography and CT operations into a single, globally‑branded organization. Samsung says...
Reimagining Migraine Treatment: Alon Ironi of Theranica on Nerivio’s Journey to Nationwide Coverage
Theranica’s Nerivio, a remote electrical neuromodulation (REN) device, has secured nationwide coverage for roughly 130 million lives through Blue Cross Blue Shield plans. The therapy’s dual acute and preventive indications offer a drug‑free alternative that expands access to underserved groups such...
United Health Services: Talkspace Acquisition Shows The New Normal For Hybrid Healthcare
United Health Services completed the acquisition of virtual behavioral health platform Talkspace at $5.25 per share, valuing the company at roughly $835 million enterprise value. The purchase brings about 6,000 licensed clinicians into UHS’s network, directly addressing chronic staffing shortages and...
Exeter Study Explores Social Camouflaging in Acquired Brain Injury
University of Exeter researchers have launched a study to determine whether people living with acquired brain injury (ABI) employ social camouflaging strategies. Led by MSc student Faye Brookes and Associate Professor Anna Adlam, the project will use a 20‑30 minute...
PromptWell and Ellipsis Health Partner to Transform AI Patient Engagement
PromptWell and Ellipsis Health have announced a partnership that merges PromptWell’s AI‑driven timing engine with Ellipsis Health’s emotionally intelligent voice agent, Sage. The combined platform predicts the exact moment a patient is most likely to answer and then engages them...
STAT+: Pharmalittle: We’re Reading About Iran War’s Impact on Pharma Supply Chain, a Pfizer Lyme Vaccine, and More
The ongoing Iran‑Israel conflict has not yet crippled global pharmaceutical supply chains, but it threatens the modest 0.3% of worldwide drug output and 0.6% of active‑pharmaceutical‑ingredient (API) production that originates in the region. Disruptions to key shipping lanes, especially the...
Lyme Vaccine Hits 70% Efficacy, Misses Confidence Threshold
The $PFE/ $VALN Lyme vaccine was a product for which there was a lot of hope. Results today show OK efficacy. Vaccine efficacy landed at 70%; investors hoped for 80% but thought as low as 60% would be relevant. But the...
Pfizer's Lyme Vaccine Data Remains Ambiguous, FDA Review Looms
As someone who lived in Vermont and still spends the summer there, it's disappointing to see the ambiguity in Pfizer's data on a new Lyme disease vaccine. It's a serious threat. Now we can move on to speculating on the...
Why GI Providers Should Care About That “Health Hack”
Patient dissatisfaction is driving a surge in DIY health hacks, especially in gastroenterology where one‑third of patients report avoiding care after negative experiences. Influencers promote trends like "fibermaxxing," urging excessive fiber intake that can aggravate conditions such as small intestinal...
Fecal pH May Predict Neurodegenerative Disease Risk
I've been saying this for the longest time, and including fecal pH in my grant applications, too I predict that we'll see a significant correlation for fecal pH with neurodegenerative diseases in future papers...
FDA OKs Fecal Transplants, Yet Access Declines
Paradox: The FDA approved some fecal transplants for C. difficile. But accessing treatment got harder. https://t.co/AFFyCGPeKW
"There Will Be No More Gaming the System" - Oz Reacts to Latest MaineCare Fraud Scandal
CMS Administrator Dr. Mehmet Oz warned Maine that Medicaid fraud will no longer be tolerated after reports that Paradise Residential Services billed over $16 million in inflated rates, charging twice the national average for autism residential care. The provider, accused of...
Phase 3 Lyme Vaccine Shows Mixed Preliminary Results
The news is mixed in the preliminary results from a Phase 3 trial of a needed #Lyme disease vaccine, @matthewherper reports. https://t.co/bcbfeXchk1
Healthcare Drives Job Growth, Outpacing National Gains
"Over the past year, the U.S. has added 156,000 jobs—but healthcare alone was responsible for 375,000 new jobs." https://t.co/85IevT4vGd
Predicting Severe Diabetes Complications Using Administrative Claims Data in Maryland
A Maryland‑wide predictive model using Medicare fee‑for‑service claims and publicly available social‑determinant data generated risk scores for 346,614 beneficiaries, released on June 7 2024. The model retained 95 statistically significant factors out of 219 candidates and produced a mean score of 0.0124,...
Why Pharma Is Exploring Direct-to-Employer Benefit Models
Pharmaceutical manufacturers are re‑examining traditional PBM‑centric distribution by offering direct‑to‑employer drug purchasing models. Companies like Andel charge a per‑prescription transaction fee and eliminate administrative or per‑member fees, aiming to lower drug spend for employers. Their platform centralizes prescription intake, routes...
Preventive Strategies to Lower Hand-Foot Syndrome Risk
Researchers published a meta‑analysis of 19 randomized trials showing that topical diclofenac gel significantly reduces the incidence of grade 2 or higher chemotherapy‑induced hand‑foot syndrome, especially in patients receiving capecitabine. The analysis also identified topical silymarin, pyridoxine 400 mg, and celecoxib as...
Somerset Indus Capital Partners Raises $288M in Fund III
Somerset Indus Capital Partners announced the closing of its third fund with $288 million in commitments, surpassing the $250 million target. The fund, backed by development finance institutions, global investors and family offices across Europe, the U.S. and Southeast Asia, will target...
Child's C. Diff Cure Required a Grueling Fecal Transplant Journey
Her son needed a fecal transplant for a fearsome C. diff infection. Getting one required a tortuous journey https://t.co/Ln54u1iTPV via @statnews
Healthcare Recruiting Platform Lands $14.5M
Carefam, a conversational AI platform for healthcare staffing, emerged from stealth with a $14.5 million Series A led by Pitango HealthTech and backed by Emerge. The solution automates candidate outreach, interview scheduling, and credential verification, escalating only complex decisions to human HR...
COVID-19 Infection May Pose Greater Risks for Developing Kidney Disease Vs. Influenza
A new retrospective cohort study of over 3 million commercially insured U.S. adults found that COVID‑19 infection dramatically increases the risk of kidney complications compared with influenza. Adjusted hazard ratios show nearly double the risk of any kidney disease (HR 1.93), a...
New Guidelines Add Testing, Therapy for ESR1‑mutated Metastatic Breast Cancer
Guideline Update Provides New Testing & Tx Recx for Pts w/ ER-Positive, HER2-Negative Met Breast Cancer w/ ESR1 Mutations [May 17-18, 2023] @ASCO Daily News - https://t.co/3ZVrEkQEN5 @DrHBurstein et al. @JCO_ASCO https://t.co/68e7D0CSgU #bcsm #PrecisionMedicine #LiquidBiopsy https://t.co/KBx2hq2BDW
Low‑
Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dexamethasone (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol https://t.co/hXxlFINejC #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm https://t.co/3Pa2TRMntk
Medicare Just Crossed $200 a Month. What It Means for Retirees
Medicare Part B premiums jumped to $202.90 a month in 2026, the first time they have cleared the $200 threshold. The Social Security cost‑of‑living adjustment added $56 to the average benefit, leaving retirees with a net gain of only about $38...
FDA Warns of Seizure Risk with some Parkinson’s Drugs
The FDA’s recent safety alert warns that high‑dose levodopa/carbidopa regimens can provoke seizures when patients develop vitamin B6 deficiency. Fourteen post‑marketing cases, including two fatalities, involved doses exceeding 1,000 mg daily and featured focal‑onset seizures that generalized. Vitamin B6 supplementation halted...
Kali Therapeutics Partners with Sanofi for KT501 in a ~$1.2B Deal
Kali Therapeutics has signed a license agreement with Sanofi granting the French giant exclusive worldwide rights to KT501, a next‑generation tri‑specific T‑cell engager aimed at B‑cell‑mediated autoimmune diseases. The deal provides Kali with $180 million in upfront and near‑term payments and...
Personalized Therapy Improves Outcomes in Residual TNBC
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer [Dec 15, 2021] Schneider et al. Radovich @JCO_ASCO https://t.co/oJm6BJrMtA #bcsm #PrecisionMedicine
Genetic Links to Aromatase Inhibitor Musculoskeletal Side Effects
Genome-Wide Associations [GWAS] and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors [Sep 20, 2010] Ingle et al. @DrWeinshilboum @JCO_ASCO https://t.co/1NJcXkWy8c #bcsm #Supponc
Oryon Cell Therapies Reports Phase 1b/2a Data Showing Sustained Motor Improvements in People with Parkinson’s Disease
Oryon Cell Therapies presented interim Phase 1b/2a data showing that its autologous dopaminergic neuron‑replacement therapy produced sustained motor improvements in Parkinson’s patients. Five participants experienced 29‑62% reductions in OFF‑state MDS‑UPDRS Part III scores over 6‑18 months, with continued gains beyond six months....
Circulating DNA/Cells Predict Recurrence Post‑Chemo in TNBC
Assoc of Circulating Tumor DNA & Circulating Tumor Cells After Neoadjuvant Chemotherapy w/ Disease Recurrence in Pts w/ Triple-Negative Breast Cancer: BRE12-158 RCT [Jul 9, 2020] Radovich et al. @JAMAOnc https://t.co/XxH9kTT9d5 #bcsm #cactc #NCT02101385 https://t.co/kgV0yM2I1f
Pfizer's Lyme Phase 3 Cut by One‑Third Over Contractor Issues
Pfizer's phase 3 for its Lyme trial was supposed to be 18k patients -- but issues with a contractor at the start of the trial cut the size by a third, and @ky_lahucik + I reported a long time ago...
If Gene Therapies Are so Revolutionary, Why Does No One Want to Pay for Them?
Gene therapies promise one‑time cures for diseases like sickle‑cell and inherited blindness, but their price tags—often $1 million to $3 million per patient—clash with the U.S. insurance model. More than half of new cell and gene therapies face coverage restrictions because insurers...
Owner of Now-Closed Milwaukee Prenatal Care Coordination Company Sentenced to 60 Months’ Imprisonment for Healthcare Fraud Scheme
Lakia Jackson, 36, was sentenced to 60 months in federal prison for a Medicaid fraud scheme that siphoned $2.66 million intended for at‑risk pregnant women and young children in Wisconsin. She pleaded guilty to healthcare fraud and aggravated identity theft after...
Liqcreate Launches Dental Resin Designed to Eliminate Separating Agents in Orthodontic and Prosthetic Acrylic Workflows
Netherlands‑based Liqcreate has launched Separation Model, a dental photopolymer that embeds a non‑adhesive agent, removing the need for separate separating media in acrylic orthodontic and prosthetic workflows. The resin is compatible with most DLP, MSLA and laser 3‑D printers operating...
P7C3 Boosts NAD Enzyme, Improves Mouse Alzheimer Model
P7C3 is an activator of an enzyme that makes NAD called NAMPT. Cool that it’s working in a 🐁 model of AD 👏
New Playbook for Private Healthcare Marketing in a Data-Driven Era
Private healthcare marketing is evolving from a standalone communications function into an integrated layer of the digital health stack, directly linked to EHRs, scheduling and telehealth platforms. This new model treats campaigns as dynamic demand‑orchestration tools that respond to real‑time...
Photon-Counting CT Better than Conventional CT in Lung Cancer
A prospective study of 200 adults compared low‑dose photon‑counting CT (PCCT) with conventional energy‑integrating detector CT for lung cancer imaging. PCCT reduced effective radiation dose by 66% (1.36 mSv vs. 4.04 mSv) and iodine load by 27%, while adverse reactions fell to...
The Future of Community-Based Healthcare Models
Community‑based healthcare is evolving from a peripheral add‑on to a primary delivery model, driven by decentralization, digital platforms, and value‑based economics. The approach embeds local clinics, health workers, and digital ecosystems to provide continuous, location‑specific care. Membership structures and managed...
Gut Health Research Is Changing Patient Care Models
Gut health research has moved from niche science to a core component of healthcare delivery. Recent FDA approval of Seres Therapeutics' Vowst and the rise of bioactive‑based microbiome products signal a shift toward industrialized, reproducible therapies. Companies across biotech, nutrition...
Under‑50 Bowel Cancer Cases Surge Globally, Linked to Lifestyle
A study published in #TheLancet Oncology reports a rise in bowel #cancer cases among people under 50 in 27 out of 50 countries over 10 years. Possible causes include obesity, gut bacteria, ultra-processed foods, and ... #healthcare #research https://t.co/Mjap7D8jtb
Henlius Receives NMPA IND Clearance for HLX18 (Biosimilar, Opdivo)
Henlius announced that China’s National Medical Products Administration (NMPA) has granted IND clearance for HLX18, a biosimilar of Opdivo (nivolumab), targeting resected solid tumours. The company also reported first‑patient dosing in Phase I trials for HLX17 (Keytruda biosimilar) and HLX13...
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Xilio Therapeutics reported a strong cash position of $137.5 million, extending its runway to the end of 2027, and highlighted significant pipeline advances. The company plans to file an IND for its bispecific PD‑1/masked IL‑2 candidate XTX501 in mid‑2026 and start...
Mobile App Development in Telehealth Matters Now More Than Ever
Telehealth has evolved from a supplemental channel into the primary interface for care delivery, driven by mature infrastructure and patient expectations. Mobile app development—especially Android due to its worldwide device penetration—has become the core conduit for patient access, provider coordination,...
Man Wins $10M Jury Verdict After ED Physicians Order Wrong Imaging Exam
A Washington man was awarded a $10 million jury verdict after emergency‑department physicians ordered the wrong imaging study, delaying treatment of a spinal epidural abscess. The misstep resulted in a 17‑hour wait, during which his paralysis progressed and became permanent. The...
Pfizer Lyme Vaccine Effective yet Misses Crucial Statistical Benchmark
Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle There is a set up for drama here. $Valn $pfe Valneva stock is down 14% in premarket trading. https://t.co/WN0KOl4Nqh via @statnews